Advertisement

Index by author

March 01, 1979; Volume 208,Issue 3

A

  1. Asano, M

    1. Contractile response of isolated rabbit aortic strips to unsaturated fatty acid peroxides.
      M Asano and H Hidaka
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 347-353;

  2. Ayala, J M

    1. Renin release by diuretics.
      L Nascimento, J M Ayala, R A Baquero and M Martinez-Maldonado
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 522-526;

B

  1. Baquero, R A

    1. Renin release by diuretics.
      L Nascimento, J M Ayala, R A Baquero and M Martinez-Maldonado
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 522-526;

  2. Barnes, D W

    1. The effects of maleic anhydride-divinyl ether (MVE) copolymers on hepatic microsomal mixed-function oxidases and other biologic activities.
      D W Barnes, P S Morahan, S Loveless and A E Munson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 392-398;

  3. Bernstein, S P

    1. Enhancement by disulfiram (Antabuse) of toxic effects of 95 to 97% O2 on the rat lung.
      S M Deneke, S P Bernstein and B L Fanburg
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 377-380;

  4. Braswell, L

    1. Actions at neuromuscular and esteratic cholinoceptive sites of some phenylene diacryloyl bis-cholinium esters.
      J J Savarese, S Ginsburg, L Braswell and R J Kitz
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 436-445;

C

  1. Clineschmidt, B V

    1. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
      B V Clineschmidt, M A McKendry, N L Papp, A B Pflueger, C A Stone, J A Totaro and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 460-467;

  2. Commissiong, J

    1. Dopaminergic control of the septal-hippocampal cholinergic pathway.
      S E Robinson, D Malthe-Sørenssen, P L Wood and J Commissiong
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 476-479;

  3. Connors, M

    1. The specificity of antimorphine and antimeperidine antibodies and their reactivity with opioid peptides.
      B H Wainer, W E Wung, M Connors and R M Rothberg
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 498-506;

  4. Constantine, J W

    1. Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator.
      J W Constantine, H M McIlhenny and P F Moore
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 371-376;

D

  1. Daniell, H B

    1. Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons.
      H B Daniell, T Walle, T E Gaffney and J G Webb
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 354-359;

  2. Davis, B B

    1. Demonstration of separate pathways for the metabolism of organic compounds in rabbit kidney.
      T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 418-421;

  3. Deneke, S M

    1. Enhancement by disulfiram (Antabuse) of toxic effects of 95 to 97% O2 on the rat lung.
      S M Deneke, S P Bernstein and B L Fanburg
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 377-380;

  4. Desnick, R J

    1. Enzyme therapy. X. Immune response induced by enzyme- and buffer-loaded liposomes in C3H/HeJ Gus(h) mice.
      L D Hudson, M B Fiddler and R J Desnick
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 507-514;

  5. Domino, E F

    1. Tele-methylhistamine oxidation by type B monoamine oxidase.
      L B Hough and E F Domino
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 422-428;

  6. Donald, A G

    1. Pharmacological effects and metabolic fate of levo-methadone during postnatal development in rat.
      N S Shah and A G Donald
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 491-497;

  7. Donoso, J A

    1. Nocodazole action on tubulin assembly, axonal ultrastructure and fast axoplasmic transport.
      F Samson, J A Donoso, I Heller-Bettinger, D Watson and R H Himes
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 411-417;

E

  1. Eaton, D L

    1. Effects of microsomal enzyme inducers on carrier-mediated transport systems in isolated rat hepatocytes.
      D L Eaton and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 381-385;

F

  1. Fanburg, B L

    1. Enhancement by disulfiram (Antabuse) of toxic effects of 95 to 97% O2 on the rat lung.
      S M Deneke, S P Bernstein and B L Fanburg
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 377-380;

  2. Fiddler, M B

    1. Enzyme therapy. X. Immune response induced by enzyme- and buffer-loaded liposomes in C3H/HeJ Gus(h) mice.
      L D Hudson, M B Fiddler and R J Desnick
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 507-514;

  3. Finkelstein, T T

    1. A role for liver glutathione in the hepatobiliary fate of N,N-dimethyl-4-aminoazobenzene.
      W G Levine and T T Finkelstein
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 399-405;

G

  1. Gaffney, T E

    1. Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons.
      H B Daniell, T Walle, T E Gaffney and J G Webb
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 354-359;

  2. Ginsburg, S

    1. Actions at neuromuscular and esteratic cholinoceptive sites of some phenylene diacryloyl bis-cholinium esters.
      J J Savarese, S Ginsburg, L Braswell and R J Kitz
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 436-445;

  3. Goldman, P

    1. The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid.
      R L Koch and P Goldman
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 406-410;

  4. Gudzinowicz, M J

    1. Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide-S-oxide in the rat.
      W R Porter, M J Gudzinowicz and R A Neal
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 386-391;

H

  1. Halushka, P V

    1. The effects of alpha adrenergic agents on human platelet aggregation.
      C Y Hsu, D R Knapp and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 366-370;

  2. Heller-Bettinger, I

    1. Nocodazole action on tubulin assembly, axonal ultrastructure and fast axoplasmic transport.
      F Samson, J A Donoso, I Heller-Bettinger, D Watson and R H Himes
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 411-417;

  3. Hidaka, H

    1. Contractile response of isolated rabbit aortic strips to unsaturated fatty acid peroxides.
      M Asano and H Hidaka
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 347-353;

  4. Himes, R H

    1. Nocodazole action on tubulin assembly, axonal ultrastructure and fast axoplasmic transport.
      F Samson, J A Donoso, I Heller-Bettinger, D Watson and R H Himes
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 411-417;

  5. Hough, L B

    1. Tele-methylhistamine oxidation by type B monoamine oxidase.
      L B Hough and E F Domino
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 422-428;

  6. Hsu, C Y

    1. The effects of alpha adrenergic agents on human platelet aggregation.
      C Y Hsu, D R Knapp and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 366-370;

  7. Hudson, L D

    1. Enzyme therapy. X. Immune response induced by enzyme- and buffer-loaded liposomes in C3H/HeJ Gus(h) mice.
      L D Hudson, M B Fiddler and R J Desnick
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 507-514;

K

  1. Kapatos, G

    1. Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes.
      G Kapatos and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 468-475;

  2. Kitz, R J

    1. Actions at neuromuscular and esteratic cholinoceptive sites of some phenylene diacryloyl bis-cholinium esters.
      J J Savarese, S Ginsburg, L Braswell and R J Kitz
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 436-445;

  3. Klaassen, C D

    1. Effects of microsomal enzyme inducers on carrier-mediated transport systems in isolated rat hepatocytes.
      D L Eaton and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 381-385;

  4. Knapp, D R

    1. The effects of alpha adrenergic agents on human platelet aggregation.
      C Y Hsu, D R Knapp and P V Halushka
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 366-370;

  5. Koch, R L

    1. The anaerobic metabolism of metronidazole forms N-(2-hydroxyethyl)-oxamic acid.
      R L Koch and P Goldman
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 406-410;

L

  1. Lau, C

    1. Accelerated development of rat sympathetic neurotransmission caused by neonatal triiodothyronine administration.
      C Lau and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 485-490;

  2. Levin, R M

    1. Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
      R M Levin and B Weiss
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 454-459;

  3. Levine, W G

    1. A role for liver glutathione in the hepatobiliary fate of N,N-dimethyl-4-aminoazobenzene.
      W G Levine and T T Finkelstein
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 399-405;

  4. Löscher, W

    1. A comparative study of the protein binding of anticonvulsant drugs in serum of dog and man.
      W Löscher
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 429-435;

  5. Loveless, S

    1. The effects of maleic anhydride-divinyl ether (MVE) copolymers on hepatic microsomal mixed-function oxidases and other biologic activities.
      D W Barnes, P S Morahan, S Loveless and A E Munson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 392-398;

M

  1. Malthe-Sørenssen, D

    1. Dopaminergic control of the septal-hippocampal cholinergic pathway.
      S E Robinson, D Malthe-Sørenssen, P L Wood and J Commissiong
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 476-479;

  2. Martinez-Maldonado, M

    1. Renin release by diuretics.
      L Nascimento, J M Ayala, R A Baquero and M Martinez-Maldonado
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 522-526;

  3. Mattammal, M B

    1. Demonstration of separate pathways for the metabolism of organic compounds in rabbit kidney.
      T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 418-421;

  4. McIlhenny, H M

    1. Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator.
      J W Constantine, H M McIlhenny and P F Moore
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 371-376;

  5. McKendry, M A

    1. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
      B V Clineschmidt, M A McKendry, N L Papp, A B Pflueger, C A Stone, J A Totaro and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 460-467;

  6. Moore, P F

    1. Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator.
      J W Constantine, H M McIlhenny and P F Moore
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 371-376;

  7. Morahan, P S

    1. The effects of maleic anhydride-divinyl ether (MVE) copolymers on hepatic microsomal mixed-function oxidases and other biologic activities.
      D W Barnes, P S Morahan, S Loveless and A E Munson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 392-398;

  8. Munson, A E

    1. The effects of maleic anhydride-divinyl ether (MVE) copolymers on hepatic microsomal mixed-function oxidases and other biologic activities.
      D W Barnes, P S Morahan, S Loveless and A E Munson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 392-398;

N

  1. Nascimento, L

    1. Renin release by diuretics.
      L Nascimento, J M Ayala, R A Baquero and M Martinez-Maldonado
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 522-526;

  2. Neal, R A

    1. Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide-S-oxide in the rat.
      W R Porter, M J Gudzinowicz and R A Neal
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 386-391;

  3. Novack, G D

    1. Anticonvulsant effects of benzhydryl piperazines on maximal electroshock seizures in rats.
      G D Novack, L G Stark and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 480-484;

O

  1. Odlind, B

    1. Relationship between tubular secretion of furosemide and its saluretic effect.
      B Odlind
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 515-521;

P

  1. Papp, N L

    1. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
      B V Clineschmidt, M A McKendry, N L Papp, A B Pflueger, C A Stone, J A Totaro and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 460-467;

  2. Peterson, S L

    1. Anticonvulsant effects of benzhydryl piperazines on maximal electroshock seizures in rats.
      G D Novack, L G Stark and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 480-484;

  3. Pflueger, A B

    1. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
      B V Clineschmidt, M A McKendry, N L Papp, A B Pflueger, C A Stone, J A Totaro and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 460-467;

  4. Porter, W R

    1. Thioacetamide-induced hepatic necrosis. II. Pharmacokinetics of thioacetamide and thioacetamide-S-oxide in the rat.
      W R Porter, M J Gudzinowicz and R A Neal
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 386-391;

  5. Powell, J R

    1. Effects of histamine on vascular sympathetic neuroeffector transmission.
      J R Powell
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 360-365;

R

  1. Robinson, S E

    1. Dopaminergic control of the septal-hippocampal cholinergic pathway.
      S E Robinson, D Malthe-Sørenssen, P L Wood and J Commissiong
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 476-479;

  2. Rothberg, R M

    1. The specificity of antimorphine and antimeperidine antibodies and their reactivity with opioid peptides.
      B H Wainer, W E Wung, M Connors and R M Rothberg
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 498-506;

S

  1. Samson, F

    1. Nocodazole action on tubulin assembly, axonal ultrastructure and fast axoplasmic transport.
      F Samson, J A Donoso, I Heller-Bettinger, D Watson and R H Himes
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 411-417;

  2. Savarese, J J

    1. Actions at neuromuscular and esteratic cholinoceptive sites of some phenylene diacryloyl bis-cholinium esters.
      J J Savarese, S Ginsburg, L Braswell and R J Kitz
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 436-445;

  3. Shah, N S

    1. Pharmacological effects and metabolic fate of levo-methadone during postnatal development in rat.
      N S Shah and A G Donald
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 491-497;

  4. Slotkin, T A

    1. Accelerated development of rat sympathetic neurotransmission caused by neonatal triiodothyronine administration.
      C Lau and T A Slotkin
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 485-490;

  5. Stark, L G

    1. Anticonvulsant effects of benzhydryl piperazines on maximal electroshock seizures in rats.
      G D Novack, L G Stark and S L Peterson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 480-484;

  6. Stone, C A

    1. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
      B V Clineschmidt, M A McKendry, N L Papp, A B Pflueger, C A Stone, J A Totaro and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 460-467;

T

  1. Totaro, J A

    1. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
      B V Clineschmidt, M A McKendry, N L Papp, A B Pflueger, C A Stone, J A Totaro and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 460-467;

W

  1. Wainer, B H

    1. The specificity of antimorphine and antimeperidine antibodies and their reactivity with opioid peptides.
      B H Wainer, W E Wung, M Connors and R M Rothberg
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 498-506;

  2. Walle, T

    1. Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons.
      H B Daniell, T Walle, T E Gaffney and J G Webb
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 354-359;

  3. Watson, D

    1. Nocodazole action on tubulin assembly, axonal ultrastructure and fast axoplasmic transport.
      F Samson, J A Donoso, I Heller-Bettinger, D Watson and R H Himes
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 411-417;

  4. Webb, J G

    1. Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons.
      H B Daniell, T Walle, T E Gaffney and J G Webb
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 354-359;

  5. Weiss, B

    1. Selective binding of antipsychotics and other psychoactive agents to the calcium-dependent activator of cyclic nucleotide phosphodiesterase.
      R M Levin and B Weiss
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 454-459;

  6. Williams, M

    1. Stereospecific antidopaminergic and anticholinergic actions of the enantiomers of (+/-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo[a,d]cyclohepten-5-ylidene) piperidine (CTC), a derivative of cyproheptadine.
      B V Clineschmidt, M A McKendry, N L Papp, A B Pflueger, C A Stone, J A Totaro and M Williams
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 460-467;

  7. Wilson, P R

    1. Spinal serotonin terminal system mediates antinociception.
      T L Yaksh and P R Wilson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 446-453;

  8. Wood, P L

    1. Dopaminergic control of the septal-hippocampal cholinergic pathway.
      S E Robinson, D Malthe-Sørenssen, P L Wood and J Commissiong
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 476-479;

  9. Wung, W E

    1. The specificity of antimorphine and antimeperidine antibodies and their reactivity with opioid peptides.
      B H Wainer, W E Wung, M Connors and R M Rothberg
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 498-506;

Y

  1. Yaksh, T L

    1. Spinal serotonin terminal system mediates antinociception.
      T L Yaksh and P R Wilson
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 446-453;

Z

  1. Zenser, T V

    1. Demonstration of separate pathways for the metabolism of organic compounds in rabbit kidney.
      T V Zenser, M B Mattammal and B B Davis
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 418-421;

  2. Zigmond, M J

    1. Effect of haloperidol on dopamine synthesis and tyrosine hydroxylase in striatal synaptosomes.
      G Kapatos and M J Zigmond
      Journal of Pharmacology and Experimental Therapeutics March 1979, 208 (3) 468-475;
Back to top

In this issue

Advertisement